tetano
Editor, Senior Moderator
Front Pharmacol. 2018 Nov 15;9:1282. doi: 10.3389/fphar.2018.01282. eCollection 2018.
[h=1]Annexins in Influenza Virus Replication and Pathogenesis.[/h] Ampomah PB[SUP]1[/SUP], Kong WT[SUP]1[/SUP], Zharkova O[SUP]1[/SUP], Chua SCJH[SUP]1[/SUP], Perumal Samy R[SUP]2[/SUP], Lim LHK[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza A viruses (IAVs) are important human respiratory pathogens which cause seasonal or periodic endemic infections. IAV can result in severe or fatal clinical complications including pneumonia and respiratory distress syndrome. Treatment of IAV infections is complicated because the virus can evade host immunity through antigenic drifts and antigenic shifts, to establish infections making new treatment options desirable. Annexins (ANXs) are a family of calcium and phospholipid binding proteins with immunomodulatory roles in viral infections, lung injury, and inflammation. A current understanding of the role of ANXs in modulating IAV infection and host responses will enable the future development of more effective antiviral therapies. This review presents a comprehensive understanding of the advances made in the field of ANXs, in particular, ANXA1 and IAV research and highlights the importance of ANXs as a suitable target for IAV therapy.
[h=4]KEYWORDS:[/h] ANXA1; FPR2; annexins; immunomodulatory; influenza virus
PMID: 30498445 PMCID: PMC6249340 DOI: 10.3389/fphar.2018.01282
Free PMC Article
[h=1]Annexins in Influenza Virus Replication and Pathogenesis.[/h] Ampomah PB[SUP]1[/SUP], Kong WT[SUP]1[/SUP], Zharkova O[SUP]1[/SUP], Chua SCJH[SUP]1[/SUP], Perumal Samy R[SUP]2[/SUP], Lim LHK[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza A viruses (IAVs) are important human respiratory pathogens which cause seasonal or periodic endemic infections. IAV can result in severe or fatal clinical complications including pneumonia and respiratory distress syndrome. Treatment of IAV infections is complicated because the virus can evade host immunity through antigenic drifts and antigenic shifts, to establish infections making new treatment options desirable. Annexins (ANXs) are a family of calcium and phospholipid binding proteins with immunomodulatory roles in viral infections, lung injury, and inflammation. A current understanding of the role of ANXs in modulating IAV infection and host responses will enable the future development of more effective antiviral therapies. This review presents a comprehensive understanding of the advances made in the field of ANXs, in particular, ANXA1 and IAV research and highlights the importance of ANXs as a suitable target for IAV therapy.
[h=4]KEYWORDS:[/h] ANXA1; FPR2; annexins; immunomodulatory; influenza virus
PMID: 30498445 PMCID: PMC6249340 DOI: 10.3389/fphar.2018.01282
Free PMC Article